Prognostic significance of thrombocytosis in renal cell carcinoma patients

International Journal of Urology

Volumn 11, Issue 6, 2004, Pages 364-367

  Inoue, Katsuki ^a,b   Kohashikawa, Kei ^a   Suzuki, Shunichi ^a   Shimada, Makoto ^a   Yoshida, Hideki ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Prognosis; Renal cell carcinoma; Thrombocytosis

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR VOLUME;

CARCINOMA, RENAL CELL; FEMALE; HEMOGLOBINS; HUMANS; JAPAN; KIDNEY NEOPLASMS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEPHRECTOMY; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOCYTOSIS;

EID: 3042742417     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00808.x     Document Type: Article

References (19)

1. Riess L. Zur pathologischen Anatomie des Blutes. Arch. Anat. Physiol. Wissensch Medical 1872; 39: 237-40.
2. Symbas NP, Townsend MF, El-Galley R et al. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int. 2000; 86: 203-7.
3. O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA. Thrombocytosis is associated with a significant increase in cancer specific death rate after radical nephrectomy. J. Urol. 2002; 168: 1378-80.
4. Hernandez E, Lavine M, Dunton CJ et al. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992; 69: 2975-7.
5. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur. Respir. J. 1996; 9: 1826-30.
6. Lavie O, Comerci G, Daras V et al. Thrombocytosis in women with vulvar carcinoma. Gyn. Oncol. 1999; 72: 82-6.
7. Lopes A, Daras V, Cross PA et al. Thrombocytosis as a Prognostic Factor in Woman With Cervical Cancer. Cancer 1994; 74: 90-92.
8. Sobin LH, Wittekind C (eds). TNM. Classification of Malignant Tumours, 5th edn. New York: Wiley, 1997.
9. Japanese Urological Association, Japanese Society of Pathology and Japan Radiological Society. General Rules for Clinical and Pathological Studies on Renal Cell Carcinoma, 3rd edn. Kanehara, Tokyo, 1999, 67-72.
10. Levin J, Conley CL. Thrombocytosis Associated With Malignant Disease. Arch. Intern. Med. 1964; 114: 497-500.
11. Sasaki Y, Takahashi T, Miyazaki H et al. Production of Thrombopoietin by Human Carcinomas and Its Novel Isoforms. Blood 1999; 94: 1952-60.
12. Gastil G, Plante M, Finstad CL et al. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br. J. Haematol. 1993; 83: 433-41.
13. Hollen CW, Henthorn J, Koziol JA et al. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br. J. Haematol. 1991; 79: 286-90.
14. Blay J, Negrier S, Combaret V et al. Serum Level of Interleukin 6 as a Prognosis Factor in Metastatic Renal Cell Carcinoma. Cancer Res. 1992; 52: 3317-22.
15. Ljungberg B, Grankvist K, Rasmuson T. Serum Interleukin-6 in Relation to acute-phase reactants and survival in Patients with Renal Cell Carcinoma. Eur. J. Can. 1997; 33: 1794-8.
16. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl. J. Med. 1971; 285: 1182-6.
17. Pinedo HM, Verheul HMW, D'Amoto RJ et al. Involvement of platelets in tumor angiogenesis? Lancet 1998; 352: 1775-177.
18. Dirix LY, Verheulen PB, Hubens G et al. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann. Oncol. 1996; 7: 843-8.
19. O'Byrne KJ, Dobbs N, Propper D et al. Vascular endothelial growths factor, platelet counts, and prognosis in renal cancer. Lancet 1999; 353: 1494-5.